TODD ROSENGART to Risk Factors
This is a "connection" page, showing publications TODD ROSENGART has written about Risk Factors.
Connection Strength
0.495
-
Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration. J Thorac Cardiovasc Surg. 2013 Nov; 146(5):1259-1266, 1266.e1; discussion 1266.
Score: 0.036
-
Risk analysis for readmission after coronary artery bypass surgery: developing a strategy to reduce readmissions. J Am Coll Surg. 2013 Mar; 216(3):412-9.
Score: 0.035
-
Driveline Infections Among Patients Supported With Left Ventricular Assist Devices: A Single Center Sixteen-Year Longitudinal Profile. Artif Organs. 2026 Apr; 50(4):572-579.
Score: 0.021
-
Tissue perfusion pressure: A novel hemodynamic measure to assess risk of acute kidney injury after cardiac surgery. J Thorac Cardiovasc Surg. 2026 02; 171(2):455-462.e3.
Score: 0.021
-
A Novel Clinical Risk Score to Predict Vasoplegia After Adult Cardiac Surgery. Ann Thorac Surg. 2025 10; 120(4):705-712.
Score: 0.020
-
Low socioeconomic status adversely influences outcomes after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2025 11; 170(5):1480-1490.e5.
Score: 0.020
-
Racial/ethnic differences persist in treatment choice and outcomes in isolated intervention for coronary artery disease. J Thorac Cardiovasc Surg. 2023 10; 166(4):1087-1096.e5.
Score: 0.016
-
Open heart surgery in the elderly: results from a consecutive series of 100 patients aged 85 years or older. Am J Med. 2002 Feb 01; 112(2):143-7.
Score: 0.016
-
Machine Learning to Predict Outcomes and Cost by Phase of Care After Coronary Artery Bypass Grafting. Ann Thorac Surg. 2022 09; 114(3):711-719.
Score: 0.016
-
Left Ventricle Mass Regression After Surgical or Transcatheter Aortic Valve Replacement in Veterans. Ann Thorac Surg. 2022 07; 114(1):77-83.
Score: 0.016
-
Allograft discard risk index for heart transplantation. Clin Transplant. 2021 11; 35(11):e14442.
Score: 0.016
-
Ninety-Day Readmission After Open Surgical Repair of Stanford Type A Aortic Dissection. Ann Thorac Surg. 2022 06; 113(6):1971-1978.
Score: 0.016
-
Outcomes of Aortic Valve Replacement for Chronic Aortic Insufficiency: Analysis of the Society of Thoracic Surgeons Database. Ann Thorac Surg. 2022 03; 113(3):763-772.
Score: 0.015
-
Consistent improvements in short- and long-term survival following heart transplantation over the past three decades. Clin Transplant. 2021 04; 35(4):e14241.
Score: 0.015
-
Development of a Risk Score to Predict 90-Day Readmission After Coronary Artery Bypass Graft. Ann Thorac Surg. 2021 02; 111(2):488-494.
Score: 0.014
-
Concomitant valve procedures in patients undergoing continuous-flow left ventricular assist device implantation: A single-center experience. J Thorac Cardiovasc Surg. 2019 10; 158(4):1083-1089.e1.
Score: 0.013
-
Incidence, Cost, and Risk Factors for Readmission After Coronary Artery Bypass Grafting. Ann Thorac Surg. 2019 06; 107(6):1782-1789.
Score: 0.013
-
Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements. J Thorac Cardiovasc Surg. 1998 Feb; 115(2):426-38; discussion 438-9.
Score: 0.012
-
In elective arch surgery with circulatory arrest, does the arterial cannulation site really matter? A propensity score analysis of right axillary and innominate artery cannulation. J Thorac Cardiovasc Surg. 2018 05; 155(5):1953-1960.e4.
Score: 0.012
-
Mitral valve surgery in the US Veterans Administration health system: 10-year outcomes and trends. J Thorac Cardiovasc Surg. 2018 01; 155(1):105-117.e5.
Score: 0.012
-
Use of cardiopulmonary pump support during coronary artery bypass grafting in the high-risk: a meta-analysis. Ir J Med Sci. 2018 May; 187(2):369-377.
Score: 0.012
-
Inferior Outcomes on the Waiting List in Low-Volume Pediatric Heart Transplant Centers. Am J Transplant. 2017 Jun; 17(6):1515-1524.
Score: 0.012
-
Aortic Stenosis. Ann Intern Med. 2017 Jan 03; 166(1):ITC1-ITC16.
Score: 0.011
-
Predicting transfusion. Ann Thorac Surg. 1996 Dec; 62(6):1885-6.
Score: 0.011
-
Incidence, Predictors, and Impact of Postoperative Atrial Fibrillation after Coronary Artery Bypass Grafting in Military Veterans. Tex Heart Inst J. 2016 Oct; 43(5):397-403.
Score: 0.011
-
Total aortic arch replacement: A comparative study of zone 0 hybrid arch exclusion versus traditional open repair. J Thorac Cardiovasc Surg. 2015 Dec; 150(6):1591-8; discussion 1598-600.
Score: 0.010
-
Changes over time in risk profiles of patients who undergo coronary artery bypass graft surgery: the Veterans Affairs Surgical Quality Improvement Program (VASQIP). JAMA Surg. 2015 Apr; 150(4):308-15.
Score: 0.010
-
Reoperations on the total aortic arch in 119 patients: short- and mid-term outcomes, focusing on composite adverse outcomes and survival analysis. J Thorac Cardiovasc Surg. 2014 Dec; 148(6):2967-72.
Score: 0.010
-
Completeness of coronary revascularization and survival: Impact of?age and off-pump surgery. J Thorac Cardiovasc Surg. 2014 Oct; 148(4):1307-1315.e1.
Score: 0.009
-
Reoperative coronary artery bypass surgery. Improved preservation of myocardial function with retrograde cardioplegia. Circulation. 1993 Nov; 88(5 Pt 2):II330-5.
Score: 0.009
-
Risk analysis of primary versus reoperative coronary artery bypass grafting. Ann Thorac Surg. 1993 Nov; 56(5 Suppl):S74-7.
Score: 0.009
-
2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg. 2012 Nov; 94(5):1761-81.
Score: 0.009
-
Abdominal mycobacterial infections in immunocompromised patients. Am J Surg. 1990 Jan; 159(1):125-31.
Score: 0.007
-
Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions. Hum Gene Ther. 2002 Jan 01; 13(1):65-100.
Score: 0.004
-
Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion. Ann Thorac Surg. 1998 Jan; 65(1):125-36.
Score: 0.003
-
A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation. 1995 Oct 15; 92(8):2236-44.
Score: 0.003